Development of Transdiagnostic Single-session Treatment

Depression Clinical Trial

Official title: Development and Clinical Trial of a Transdiagnostic Single-session Treatment for Primary Care Patients

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to test a single session treatment program in primary care patients with anxiety and/or depression and/or stress-related issues. The main questions it aims to answer is:

• Will the transdiagnostic treatment program decrease symptoms of depression/anxiety/stress?

• Will the transdiagnostic treatment program decrease transdiagnostic risk factors?

• Will the transdiagnostic treatment program decrease the measured risk factors equally?

• Will the transdiagnostic treatment program impact patients with anxiety, depression or stress disorders equally?

• Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on transdiagnostic risk factors?

• Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on anxiety, depression, or stress-symptoms?

• Have the participants been able to generalize the skills taught in the program(qualitative)?

• Within group that were treated with single-session treatment and recieved additional care before follow-up, was there a difference in outcome?

Clinical Trial Description

The study investigates the effect of a single-session, 4 hour, transdiagnostic treatment for primary care patientst with depression, anxiety or stress.

The treatment includes, interoceptive exposure, behavioral activation, mindfulness, defusion and psycho-education about emotions.

The study is conducted in a clinical setting in northern sweden and follows up results at 3 weeks and 6 months post treatment. ;

Related Conditions & MeSH terms

• Anxiety Disorders
• Depression
• Stress Disorder

• NCT number: NCT05784259
• Study type: Interventional
• Source: Luleå Tekniska Universitet
• Contact: John Näsling, Master
• Phone: +4673 080 77 67
• Email: john.nasling@ltu.se
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2023
• Completion date: January 2025